Casi DeYoung

Casi DeYoung

Corporate Officer/Principal chez SHATTUCK LABS, INC.

Fortune : 509 951 $ au 30/06/2026

55 ans
Health Technology
Commercial Services
Consumer Services

Profil

Casi DeYoung is currently Chief Business Officer at Shattuck Labs, Inc. since 2019.
Former roles include Operations Director-Oncology at Merck KGaA, Operations Director-Oncology at EMD Pharmaceuticals, Inc. from 2000 to 2005, Consulting Manager at Accenture Ltd., Vice President-Business Development at Reata Pharmaceuticals, Inc. from 2008 to 2013, Vice President-Business Development at ODC Therapy, Inc. from 2005 to 2008, Chief Business Officer at Mirna Therapeutics, Inc. from 2014 to 2017, and Chief Operating Officer & Vice President at ImmuneSensor Therapeutics, Inc. from 2018 to 2019.
Education includes undergraduate studies at Southwestern University and an MBA from McCombs School of Business.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
25/01/2026 73 480 ( 0,08 % ) 509 951 $ 30/06/2026

Postes actifs de Casi DeYoung

SociétésPosteDébut
SHATTUCK LABS, INC. Corporate Officer/Principal 01/12/2019

Anciens postes connus de Casi DeYoung

SociétésPosteFin
Directeur des opérations 01/12/2019
Public Communications Contact 01/06/2017
REATA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/12/2013
Corporate Officer/Principal 01/03/2008
Corporate Officer/Principal 01/01/2005
Voir l'expérience en détail de Casi DeYoung

Formation de Casi DeYoung

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

35

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Commercial Services

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Casi DeYoung
🔇